PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
Visit https://www.peervoice.com/YWF860 to view the entire programme with slides. After completing “Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022”, participants will be able to: Describe key safety and efficacy data for targeted and immunotherapies in molecular biomarker-positive non-small-cell lung cancer (NSCLC); Determine the impact and clinical implications of new evidence on the current treatment landscape in NSCLC; and Apply new data to improve the care and outcomes of patients with NSCLC.